Cached score snapshot

US.DGX · Quest Diagnostics

110分制 55/110;5D動能v2 3/50;排序分 58/160

Ranking score 58/160
Main score 55/110
5D momentum v2 3/50
Rank #196
Setup grade F 26.1

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 26.1 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 07-02 09-04 10-08 10-23 11-06 $193.89$245.44$297.00 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.509 · anchors 120 +1.52% -1.63% / +3.77% 65% 2.5% Actual -1.38% · vs median -2.90% · inside 25-75 band
30D observation +7.67% +4.46% / +14.12% 87.5% 0% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.63% -1.49% / +2.66% 58.1% 3.8% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-07-02 → 2026-11-06 · 177 archived points · 1 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 58
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 55/110 (觀望)
5D momentum v2 3/50 (弱)
Score with momentum v2 58/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 239.262
ma50 235.7046
close 236.32
prevClose 236.59
avgVolume20 1102050
volumeRatio 0.67
changePercent -0.11

Metrics snapshot

close 236.32
volume 741700
changePercent -0.11

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 55/110
Main rating 觀望
5D momentum v2 3/50
Score with momentum v2 58/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.7/5 · 良好

Dimension score 3.7/5
Dimension grade 良好

Sub-items

pbPoints 0.4
pePoints 0.4
epsPoints 0.4
roePoints 0.4
debtPoints 0.4
marginPoints 0
turnoverUsdM 175.2786
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 10/20 · 較差

Dimension score 10/20
Dimension grade 較差

Sub-items

cmfPoints 1.6
mfiPoints 1.6
obvPoints 4
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.DGX
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 11/15 · 良好

Dimension score 11/15
Dimension grade 良好

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 14.21

trend

score 4

details

qqq

ma20 720.8745
ma50 712.6536
name QQQ
close 744.5
points 2

spy

ma20 765.3505
ma50 761.5658
name SPY
close 771.35
points 2
source twelvedata+fred
atrPct 2.5785
atrPoints 3
cciPoints 1.6
vixPoints 2.4
marketTrendPoints 4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 7
catalystCount 0
catalystPoints 2

風險管理 — 6.6/10 · 一般

Dimension score 6.6/10
Dimension grade 一般

Sub-items

position

score 1.4

details

atrPct 2.5785
turnoverUsdM 175.2786
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.DGX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 224.1328

strength_details

ma_score 2
atr_score 2
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.2
take_profit_price 248.136
target_multiplier 1.6
technical_strength 1.48
take_profit_percent 5
positionPoints 1.4
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.1571
diversificationPoints 2

技術信號 — 17.7/30 · 較差

Dimension score 17.7/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 2.4
vcpPoints 0.4
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 0.4
vcp_reason 站上MA50;Ready=N;Confirm=N

vcp_metrics

up_days 4
vol_ref 1007403.3333
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 1289130
avg_vol_20 1106955
avg_vol_30 1007403.3333
range_pct_10 0.0914
range_pct_20 0.0914
range_pct_30 0.0914
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 1.2797
dist_to_20d_high 0.0503
down_shrink_days 1
breakout_level_20d 248.84
vcp_breakout_confirm false
contraction_ratio_10_30 1
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 2.4
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 1
volumePointsTechnical 0.4

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 7
negativeHits 0
positiveHits 2
sentimentScoreRaw 0.7

sentimentData

raw {"id":142363328,"url":"https://finnhub.io/api/news?id=04ca053e648e9f19e903df7b13d3267b9144e1d464ad58573b2654ed36a9ed7f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) drew fresh attention after announcing an Apple Health integration that allows iPhone and iPad users to order a preventive lab panel with more than 50 biomarkers for US$119. The Apple Health tie-in lands after a strong run in Quest Diagnostics’ shares, with the price up 15.6% over 90 days and 35.1% year to date, even though the last month’s share price return slipped 3.9% as traders reassessed shorter term risk and reward. Scan beyond Quest Diagnostics and see how other...","category":"company","datetime":1790183582,"headline":"Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch"}, {"id":142343168,"url":"https://finnhub.io/api/news?id=038be9e8835d6646a1edcfd73c166a149aa77b0857c0e85a501ba91781969b3a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics has delivered a strong run in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current share price still aligned with the cash the business is expected to generate over time, or has sentiment moved ahead of its underlying economics? Over the past 3 years, Quest Diagnostics has returned 108.9%, which puts real weight on whether that gain is grounded in durable cash flows rather than just multiple expansion. A recent...","category":"company","datetime":1790111776,"headline":"Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns"}, {"id":142338105,"url":"https://finnhub.io/api/news?id=0ddb1180ed60687db2d4be2df12a1369e2e796f69a49ec3ce7f075a2a7dce3bb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.","category":"company","datetime":1790080080,"headline":"Is This the Right Time to Add DGX Stock to Your Portfolio?"}, {"id":142195441,"url":"https://finnhub.io/api/news?id=1ffb6b8ee640f62a432d9ed6fc9c97319640f57308c68c080f2c1ff301be27ab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1789564502,"headline":"Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?"}, {"id":142166319,"url":"https://finnhub.io/api/news?id=2e026f55abbf3ff2290abb66c1cf389d6e9b119a0016b17e326f84773da4e2c6","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"DGX","summary":"Quest Diagnostics Incorporated (DGX) 2026 Global Healthcare Conference September 15, 2026 10:50 AM EDTCompany ParticipantsJames Davis - Chairman, CEO &...","category":"company","datetime":1789480905,"headline":"Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript"}, {"id":142138925,"url":"https://finnhub.io/api/news?id=bad7a27a955426b55fb09f9a409ec2144d8329e93442bc5c62eaa70c361e1be8","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"DGX","summary":"Quest Diagnostics Incorporated (DGX) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsSam Samad -...","category":"company","datetime":1789391505,"headline":"Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"}, {"id":141408008,"url":"https://finnhub.io/api/news?id=7e265a133c957b1e633a2178b581bff46b7f58d4be1a68ea313b16f299e10419","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood-based Alzheimer’s tests accessible through Quest’s U.S. collection network. Together, these moves highlight Quest’s push to deepen its role in advanced kidney, brain health, and consumer-oriented wellness testing...","category":"company","datetime":1788498563,"headline":"Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX"}
raw_source {"id":142424964,"url":"https://finnhub.io/api/news?id=6754993483ef0493cde9e75b72cce17e5c23c7eabbdaa8d127e95ef24b3b6fed","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"DGX's 36.3% YTD rise reflects momentum in advanced diagnostics, channel growth, AI adoption and cost savings.","category":"company","datetime":1790334840,"headline":"Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?"}, {"id":142363328,"url":"https://finnhub.io/api/news?id=04ca053e648e9f19e903df7b13d3267b9144e1d464ad58573b2654ed36a9ed7f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) drew fresh attention after announcing an Apple Health integration that allows iPhone and iPad users to order a preventive lab panel with more than 50 biomarkers for US$119. The Apple Health tie-in lands after a strong run in Quest Diagnostics’ shares, with the price up 15.6% over 90 days and 35.1% year to date, even though the last month’s share price return slipped 3.9% as traders reassessed shorter term risk and reward. Scan beyond Quest Diagnostics and see how other...","category":"company","datetime":1790183582,"headline":"Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch"}, {"id":142357932,"url":"https://finnhub.io/api/news?id=9e36425fe178bc4709a47624582e481fa85510e74d1222fa56d6866a9e993d90","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700551/image_2172700551.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"DGX","summary":"Quest Diagnostics outlook: recurring testing demand & acquisitions support growth via hospital partnerships, dialysis & advanced diagnostics. More on DGX stock.","category":"company","datetime":1790153451,"headline":"Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds"}, {"id":142343168,"url":"https://finnhub.io/api/news?id=038be9e8835d6646a1edcfd73c166a149aa77b0857c0e85a501ba91781969b3a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics has delivered a strong run in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current share price still aligned with the cash the business is expected to generate over time, or has sentiment moved ahead of its underlying economics? Over the past 3 years, Quest Diagnostics has returned 108.9%, which puts real weight on whether that gain is grounded in durable cash flows rather than just multiple expansion. A recent...","category":"company","datetime":1790111776,"headline":"Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns"}, {"id":142343169,"url":"https://finnhub.io/api/news?id=f51891e6b50a33e2225807bf2c70868ec49a46eace8ca870fd0fa16effd1209e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its third quarter 2026 financial results on Thursday, October 22, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.","category":"company","datetime":1790108880,"headline":"Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026"}, {"id":142340992,"url":"https://finnhub.io/api/news?id=7f9451e056dd0c45a4304b88f0f9ccd9306f02bc7a8be5192dacae80dd8a134d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Stock Market Today: The Dow Jones index was lower after President Trump threatened Iran at the UN. Apple stock is near a buy point.","category":"company","datetime":1790098711,"headline":"Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)"}, {"id":142340543,"url":"https://finnhub.io/api/news?id=3676ae49763de619be9f5fe2e63a7f07bcf3e24bbc465dc75e6bdb876230f298","image":"https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp","source":"ChartMill","related":"DGX","summary":"Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.","category":"company","datetime":1790096700,"headline":"These S&P500 stocks have an unusual volume in today's session"}, {"id":142340388,"url":"https://finnhub.io/api/news?id=f2b585db9bcaae9e84130e615a8e8ef41261f486b04f1b7c75b84e8417f50f6d","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"DGX","summary":"Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.","category":"company","datetime":1790094901,"headline":"These S&P500 stocks are moving in today's session"}, {"id":142340108,"url":"https://finnhub.io/api/news?id=7ba6201b058414a5b6972eb4c07b92c2f611694434c01ec3676864195808afe1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"The government thinks it's been overpaying Quest Diagnostics. They plan to stop doing that next year.","category":"company","datetime":1790092667,"headline":"Why Quest Diagnostics Holdings Stock Dropped Today"}, {"id":142339965,"url":"https://finnhub.io/api/news?id=d1b6e8b524d0647dcaeec0b1a5b6abcaaf33defc75d8f66fc0c8d15a8e837148","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid whole genome and exome sequencing, next-generation sequencing, chromosomal microarrays and personalized neonatal care. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes key trends, technologies, segments, regional opportunities and leading companies, in","category":"company","datetime":1790092440,"headline":"NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)"}, {"id":142339145,"url":"https://finnhub.io/api/news?id=f0446e18c84e837a73cc227d0f99d6763ecece1442cb743bfc7cda0da9c0f348","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"DGX","summary":"Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.","category":"company","datetime":1790087701,"headline":"What's going on in today's session: S&P500 gap up and gap down stocks"}, {"id":142338103,"url":"https://finnhub.io/api/news?id=4401faec34b0aaa7836bc4c94e2745f0faaa5a933c0af5da81443dbec3f44bcb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.","category":"company","datetime":1790085600,"headline":"Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure"}, {"id":142338104,"url":"https://finnhub.io/api/news?id=5215abeb2634d2e41b0915055aa5ef030cbf4b8eecbec9bed4a3c64d0351b745","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) and Labcorp (LH) shares fell in Tuesday premarket trading after the Centers","category":"company","datetime":1790081212,"headline":"Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services"}, {"id":142337151,"url":"https://finnhub.io/api/news?id=ec15db9f3538528033e3a2b785c80a05463d3015aa798d3d099f3d82dfb34f1d","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"DGX","summary":"Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.","category":"company","datetime":1790080501,"headline":"Discover the top S&P500 movers in Tuesday's pre-market session."}, {"id":142338105,"url":"https://finnhub.io/api/news?id=0ddb1180ed60687db2d4be2df12a1369e2e796f69a49ec3ce7f075a2a7dce3bb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.","category":"company","datetime":1790080080,"headline":"Is This the Right Time to Add DGX Stock to Your Portfolio?"}, {"id":142340903,"url":"https://finnhub.io/api/news?id=0038cdfe7ff456daae6d1d328d374892016f3ea30e0fa66c2020ba00ba32c252","image":"https://image.cnbcfm.com/api/v1/image/107419247-1716474869682-gettyimages-2120209340-64393_48_ms_2421.jpeg?v=1790098111&w=1920&h=1080","source":"CNBC","related":"DGX","summary":"These are the stocks posting the largest moves midday.","category":"company","datetime":1790079522,"headline":"Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more"}, {"id":142341306,"url":"https://finnhub.io/api/news?id=a71b9de87d209370f6319257c8942174ad27d5b639cb870a2f9cf782b0777741","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics has outperformed the Nasdaq over the past year, and analysts are moderately optimistic about the stock’s prospects.","category":"company","datetime":1790078212,"headline":"Is Quest Diagnostics Stock Outperforming the Nasdaq?"}, {"id":142336978,"url":"https://finnhub.io/api/news?id=f1182ee95aa158cd4e64c93fec0fe6aa89a804fc357f25c80bbb04d312374656","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Investing.com - U.S. stock index futures steadied on Tuesday, following a strong session on Wall Street that saw the benchmark S&P 500 post its best day since August, helped by gains in artificial intelligence-linked stocks.","category":"company","datetime":1790078144,"headline":"Premarket movers: Quest, Labcorp hit by CMS cuts"}, {"id":142338041,"url":"https://finnhub.io/api/news?id=3e0d174be2c852517a09542bfcb22c078c10e5aab66134bc391405284e08e1bf","image":"https://cdn.benzinga.com/files/images/story/2026/09/22/Portland--Or--Usa---Sep-4--2025-Homepage.jpg?width=2048&height=1536","source":"Benzinga","related":"DGX","summary":"CMS proposes 2027 Medicare lab rates, estimating $1 billion in annual taxpayer savings as payments align with private rates.","category":"company","datetime":1790064655,"headline":"CMS Targets $1 Billion in Annual Savings With new Medicare Lab Payment Rates — Here’s What Could Change in 2027"}, {"id":142338042,"url":"https://finnhub.io/api/news?id=5fbe59656eb7c8e519203883d87a9ba7e725d627ad9c93744d9bd2b9cb6b416c","image":"https://cdn.benzinga.com/files/images/story/2026/09/22/Stockholm--Sweden---October-8--2021-An-O.jpg?width=2048&height=1536","source":"Benzinga","related":"DGX","summary":"U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostics, Rambus and others also declined premarket.","category":"company","datetime":1790064067,"headline":"Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session"}, {"id":142340847,"url":"https://finnhub.io/api/news?id=1a3dcec5e48d410e2b1bfe59cbaf3923fc48e925527b6fa1ef1214e10e7de391","image":"https://image.cnbcfm.com/api/v1/image/108192542-17564859632025-08-29t163100z_183075094_rc28ggaso5se_rtrmadp_0_on-hldg-results.jpeg?v=1756486078&w=1920&h=1080","source":"CNBC","related":"DGX","summary":"These are the stocks posting the largest moves in early trading.","category":"company","datetime":1790063373,"headline":"Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more "}, {"id":142337396,"url":"https://finnhub.io/api/news?id=7491d828c68bc1cb16df1464f12b93a2ed591c42e1565441c46468c4b46e2e1e","image":"https://cdn.benzinga.com/files/images/story/2026/09/22/The-Real-Villains-No-Longer-Hide.jpg?width=2048&height=1536","source":"Benzinga","related":"DGX","summary":"Vicor jumped 11% premarket after raising Q3 growth guidance above 20%; TOPS, FBGL and QNME led other gainers.","category":"company","datetime":1790055031,"headline":"Why Vicor Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket"}, {"id":142337470,"url":"https://finnhub.io/api/news?id=5c389d182d0729ba00bed5398594278c770ae22bb653f7a50cf68140cd412bc9","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=2048&height=1536","source":"Benzinga","related":"DGX","summary":"Gainers\n\nMilestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. \nEvotec (NASDAQ:EVO) stock rose 8.44% to","category":"company","datetime":1790010367,"headline":"12 Health Care Stocks Moving In Monday's After-Market Session"}, {"id":142314530,"url":"https://finnhub.io/api/news?id=351177f1d47b514bcc8a183bc924d38c93b7558751778d3c960cf36c2c1941b3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (NYSE:DGX) CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth, consumer-health demand and partnerships rather than a heavier-than-expected pace of acquisitions. D","category":"company","datetime":1789999330,"headline":"Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges"}, {"id":142311097,"url":"https://finnhub.io/api/news?id=549978088471503f39ef8adfc2316186f5ce7fc93dab84136070f50605ea2d73","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Market uncertainty persists, but Zacks highlights strong gains across key portfolios and stocks, including PBF, PLTR and ADBE","category":"company","datetime":1789992600,"headline":"Beat the Market Like Zacks: PBF, Palantir, Adobe in Focus"}, {"id":142313054,"url":"https://finnhub.io/api/news?id=3c78eb32d5eeb8295fa80c578cf9e54fa18cb97df559f696903c7f45af3604e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Nearly one in three patients found to have antibodies against the bacterium that causes Lyme disease also had antibodies against one or more additional tick-borne pathogens, according to a new study by researchers from Quest Diagnostics (NYSE: DGX) and the University of North Carolina at Chapel Hill.","category":"company","datetime":1789992180,"headline":"Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics"}, {"id":142312445,"url":"https://finnhub.io/api/news?id=a88fe3314c79e8d454a01552d14cb77e1a9437dff5db27b2ceaee866cb1d31e5","image":"","source":"Benzinga","related":"DGX","summary":"Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target from $250 to $260.","category":"company","datetime":1789981671,"headline":"Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $260"}, {"id":142312446,"url":"https://finnhub.io/api/news?id=b85e02d4bea66182a8dbb2ce386581296b35e69bfed6c8f4ef67278e22f613e0","image":"","source":"Benzinga","related":"DGX","summary":"New study by researchers from Quest Diagnostics (NYSE:DGX) and the University of North Carolina at Chapel Hill. Published in JAMA Network Open, the study, titled "Coseropositivity to Tick-Borne Pathogens Among","category":"company","datetime":1789978088,"headline":"Quest Diagnostics Study Indicates That Nearly One In Three Patients With Antibodies Against Bacterium That Causes Lyme Disease Also Had Antibodies Against One Or More Additional Tick-Borne Pathogens"}, {"id":142225152,"url":"https://finnhub.io/api/news?id=355c03f661bd93e470abbdb17b5b22b8907769b7958f9e4c607be6bc4b7480f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Fed hikes rates and signals another, putting MGEE, ADM, DOLE and DGX in focus as low-beta defensive picks.","category":"company","datetime":1789649760,"headline":"Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive Picks"}, {"id":142195441,"url":"https://finnhub.io/api/news?id=1ffb6b8ee640f62a432d9ed6fc9c97319640f57308c68c080f2c1ff301be27ab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1789564502,"headline":"Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?"}, {"id":142195442,"url":"https://finnhub.io/api/news?id=5f49404a1d066bb0c796e28f63a739f547f3fa8629f60e677951b1751d8a54fa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"A new national survey finds the overwhelming majority of American voters rely on diagnostic laboratory testing to guide their healthcare decisions and are deeply concerned about scheduled Medicare payment cuts that could put that access at risk.","category":"company","datetime":1789560180,"headline":"Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics"}, {"id":142167113,"url":"https://finnhub.io/api/news?id=b9533ba462e02bc4cdd69ebe009cce3b112c1338397a301218653d5b059ea426","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"DGX","summary":"Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.","category":"company","datetime":1789499101,"headline":"Discover which S&P500 stocks are making waves on Tuesday."}, {"id":142166319,"url":"https://finnhub.io/api/news?id=2e026f55abbf3ff2290abb66c1cf389d6e9b119a0016b17e326f84773da4e2c6","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"DGX","summary":"Quest Diagnostics Incorporated (DGX) 2026 Global Healthcare Conference September 15, 2026 10:50 AM EDTCompany ParticipantsJames Davis - Chairman, CEO &...","category":"company","datetime":1789480905,"headline":"Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript"}, {"id":142194774,"url":"https://finnhub.io/api/news?id=d1cab808ccf45cf13f1263e44cacc1adc587155103fca3659b6bbe4aa4db95f1","image":"https://cdn.benzinga.com/files/images/story/2026/09/15/Stock-Market-Graph-Crashing-Down--Wall-S.jpg?width=2048&height=1536","source":"Benzinga","related":"DGX","summary":"The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.","category":"company","datetime":1789478829,"headline":"10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today"}, {"id":142138925,"url":"https://finnhub.io/api/news?id=bad7a27a955426b55fb09f9a409ec2144d8329e93442bc5c62eaa70c361e1be8","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"DGX","summary":"Quest Diagnostics Incorporated (DGX) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsSam Samad -...","category":"company","datetime":1789391505,"headline":"Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"}, {"id":142029718,"url":"https://finnhub.io/api/news?id=df890eec6f1a2d6097b529a61c7a9ae646433d195e74ad03041a926884182cd9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a tailored Quest laboratory test panel that includes over 50 biomarkers directly through the app on iPhone and iPad later this year. Apple first announced the upcoming update today at its September event.","category":"company","datetime":1788984060,"headline":"Apple Health app Users to be Able to Order Labs from Quest Diagnostics"}, {"id":141951221,"url":"https://finnhub.io/api/news?id=5f0ccb5ba37ed2618b1c737f27fa3e8f9f760cf7074a72a068ccba82d24d4b12","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"J. E. Davis disposed of 8% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement, retaining $28.9 million in company stock.","category":"company","datetime":1788873661,"headline":"Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million"}, {"id":142027783,"url":"https://finnhub.io/api/news?id=800342fa032d4ffa9f0fe8c6eacc7f273f4182a62ae6d9c3a561f8cf138becb2","image":"","source":"Benzinga","related":"DGX","summary":"UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $232 to $245.","category":"company","datetime":1788872310,"headline":"UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $245"}, {"id":141481712,"url":"https://finnhub.io/api/news?id=32dc6369c8c4692854a03ad7a10e5e7b739bfc7119a1fc5618cdb3c137eb677e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access. Roche Holding AG and Eli Lilly and Company (NYSE:LLY) may now have a simpler way to help physicians evaluate certain patients. The FDA has cleared Elecsys pTau217, which is a blood test that helps identify whether […]","category":"company","datetime":1788568671,"headline":"Could Roche and Lilly’s Blood Test Make Alzheimer’s Assessment More Accessible?"}, {"id":141438225,"url":"https://finnhub.io/api/news?id=2bf55cc0ae8c14624d700fbe2bf2c06157061782e7f4dc6e23aa264b1b3689a5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"The global clinical laboratory services market was valued at USD 274.6 billion in 2025 and is forecast to reach USD 468.2 billion by 2036, rising from USD 298.4 billion in 2026 at a 4.6% CAGR. Growth is driven by chronic diseases, preventive healthcare, molecular diagnostics, genomic testing, precision medicine, laboratory automation, AI-enabled diagnostics, and at-home testing. North America leads, while Asia-Pacific is set for the fastest growth. The report analyzes key segments, regions, oppo","category":"company","datetime":1788532680,"headline":"Clinical Laboratory Services Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)"}, {"id":141408008,"url":"https://finnhub.io/api/news?id=7e265a133c957b1e633a2178b581bff46b7f58d4be1a68ea313b16f299e10419","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood-based Alzheimer’s tests accessible through Quest’s U.S. collection network. Together, these moves highlight Quest’s push to deepen its role in advanced kidney, brain health, and consumer-oriented wellness testing...","category":"company","datetime":1788498563,"headline":"Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX"}, {"id":141400633,"url":"https://finnhub.io/api/news?id=595b73bf89e80d13752af49c883469a8239d7018da51accdfc2ed2fe3801f203","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788449411,"headline":"Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?"}, {"id":141362285,"url":"https://finnhub.io/api/news?id=7cc64918f3b60782ab2fbcbefa34e6aa0b5f06d064dc3153c595d7e299f4f42e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.","category":"company","datetime":1788208182,"headline":"Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest"}
data_source finnhub_news_keyword_model
article_count 7
negative_hits 0
positive_hits 2
recomputed_at_score true
sentiment_score_raw 0.7
source_article_count 43
discarded_article_count 36
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.7 5/110 74% 3.7
資金流 10 20/110 50% 10
市場環境 11 15/110 73.33% 11
催化劑 2 20/110 10% 2
風險管理 6.6 10/110 66% 6.6
技術信號 17.7 30/110 59% 17.7
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 3/50
ret_5d -0.0411
max_score 50
max_total 50
raw_total 3
vcp_bonus 0
vol_ratio 0.67
ret_points 0
vol_points 0
range_ratio 0.5126
volat_points 0
day_range_pct 0.0117
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.5785
turnoverUsdM 175.2786
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.DGX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 224.1328

strength_details

ma_score 2
atr_score 2
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.2
take_profit_price 248.136
target_multiplier 1.6
technical_strength 1.48
take_profit_percent 5
positionPoints 1.4
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.1571
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.7/5分
資金流分析總分: 10/20分
市場環境分析總分: 11/15分
催化劑分析: 2/20分
風險管理總分: 6.6/10分
技術信號分析總分: 17.7/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 71.43
atr
atr 6.0936
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.58
cci
rule Cursor_18.24 CCI bands
level 弱勢
score 4
value -38.36
cmf
rule Cursor_18.24 CMF bands
level 平衡
score 4
value 0.0934
kdj
d 55.1
j 30.85
k 47.01
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 弱流入
score 4
value 49.95
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value -9295400
recentSlope -413300
previousSlope -350840
rsi
value 48.99
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 234.8186
position SAR喺價下
distancePct 0.64
previousTrend 上升
ma50
value 235.7046
macd
macd 0.5199
trend 中性偏多
signal 1.576
histogram -1.0561
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 239.05
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 空升
ratio 0.67
score 2
avgVolume 1102050
currentVolume 741700
derived
ma20 239.262
ma50 235.7046
prevClose 236.59
avgVolume10 1263620
avgVolume20 1102050
changePercent -0.11
avgVolumeForScore 1102050
ma_cross
ma20 239.262
ma50 235.7046
rule Cursor_18.24 MA20/MA50 cross
cross 接近
score 6
prevMa20 239.6765
prevMa50 235.1664
spreadPct 1.51
isVolumeBreakout false
bollinger
lower 229.3454
upper 249.1786
position 中間
rsi_short
value 19.61
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.67

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.578537467055795,
        "turnoverUsdM": 175.278551417,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DGX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 224.1328,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.2,
      "take_profit_price": 248.136,
      "target_multiplier": 1.6,
      "technical_strength": 1.48,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.15707493411159,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 58,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 55,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 239.262,
    "ma50": 235.7046,
    "close": 236.32,
    "prevClose": 236.59,
    "avgVolume20": 1102050,
    "volumeRatio": 0.67,
    "changePercent": -0.11
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.04110363156826935,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.6700362706704428,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.5126494421054463,
      "volat_points": 0,
      "day_range_pct": 0.011721394223028385,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 58,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 74,
        "contribution": 3.7
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 11,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 73.33,
        "contribution": 11
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 17.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 59,
        "contribution": 17.7
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 55,
    "details": [
      "基本面分析總分: 3.7/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 11/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 17.7/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.7,
      "資金流": 10,
      "市場環境": 11,
      "情緒分析": 4,
      "技術信號": 17.7,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.4,
          "epsPoints": 0.4,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 175.278551417,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DGX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 720.8744953000001,
                "ma50": 712.6535974199999,
                "name": "QQQ",
                "close": 744.5,
                "points": 2
              },
              "spy": {
                "ma20": 765.3504968,
                "ma50": 761.5657979799997,
                "name": "SPY",
                "close": 771.34998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.578537467055795,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.7
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142363328,
                "url": "https://finnhub.io/api/news?id=04ca053e648e9f19e903df7b13d3267b9144e1d464ad58573b2654ed36a9ed7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) drew fresh attention after announcing an Apple Health integration that allows iPhone and iPad users to order a preventive lab panel with more than 50 biomarkers for US$119. The Apple Health tie-in lands after a strong run in Quest Diagnostics’ shares, with the price up 15.6% over 90 days and 35.1% year to date, even though the last month’s share price return slipped 3.9% as traders reassessed shorter term risk and reward. Scan beyond Quest Diagnostics and see how other...",
                "category": "company",
                "datetime": 1790183582,
                "headline": "Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch"
              },
              {
                "id": 142343168,
                "url": "https://finnhub.io/api/news?id=038be9e8835d6646a1edcfd73c166a149aa77b0857c0e85a501ba91781969b3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics has delivered a strong run in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current share price still aligned with the cash the business is expected to generate over time, or has sentiment moved ahead of its underlying economics? Over the past 3 years, Quest Diagnostics has returned 108.9%, which puts real weight on whether that gain is grounded in durable cash flows rather than just multiple expansion. A recent...",
                "category": "company",
                "datetime": 1790111776,
                "headline": "Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns"
              },
              {
                "id": 142338105,
                "url": "https://finnhub.io/api/news?id=0ddb1180ed60687db2d4be2df12a1369e2e796f69a49ec3ce7f075a2a7dce3bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.",
                "category": "company",
                "datetime": 1790080080,
                "headline": "Is This the Right Time to Add DGX Stock to Your Portfolio?"
              },
              {
                "id": 142195441,
                "url": "https://finnhub.io/api/news?id=1ffb6b8ee640f62a432d9ed6fc9c97319640f57308c68c080f2c1ff301be27ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1789564502,
                "headline": "Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?"
              },
              {
                "id": 142166319,
                "url": "https://finnhub.io/api/news?id=2e026f55abbf3ff2290abb66c1cf389d6e9b119a0016b17e326f84773da4e2c6",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (DGX) 2026 Global Healthcare Conference September 15, 2026 10:50 AM EDTCompany ParticipantsJames Davis - Chairman, CEO &...",
                "category": "company",
                "datetime": 1789480905,
                "headline": "Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript"
              },
              {
                "id": 142138925,
                "url": "https://finnhub.io/api/news?id=bad7a27a955426b55fb09f9a409ec2144d8329e93442bc5c62eaa70c361e1be8",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (DGX) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsSam Samad -...",
                "category": "company",
                "datetime": 1789391505,
                "headline": "Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 141408008,
                "url": "https://finnhub.io/api/news?id=7e265a133c957b1e633a2178b581bff46b7f58d4be1a68ea313b16f299e10419",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood-based Alzheimer’s tests accessible through Quest’s U.S. collection network. Together, these moves highlight Quest’s push to deepen its role in advanced kidney, brain health, and consumer-oriented wellness testing...",
                "category": "company",
                "datetime": 1788498563,
                "headline": "Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX"
              }
            ],
            "raw_source": [
              {
                "id": 142424964,
                "url": "https://finnhub.io/api/news?id=6754993483ef0493cde9e75b72cce17e5c23c7eabbdaa8d127e95ef24b3b6fed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DGX's 36.3% YTD rise reflects momentum in advanced diagnostics, channel growth, AI adoption and cost savings.",
                "category": "company",
                "datetime": 1790334840,
                "headline": "Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?"
              },
              {
                "id": 142363328,
                "url": "https://finnhub.io/api/news?id=04ca053e648e9f19e903df7b13d3267b9144e1d464ad58573b2654ed36a9ed7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) drew fresh attention after announcing an Apple Health integration that allows iPhone and iPad users to order a preventive lab panel with more than 50 biomarkers for US$119. The Apple Health tie-in lands after a strong run in Quest Diagnostics’ shares, with the price up 15.6% over 90 days and 35.1% year to date, even though the last month’s share price return slipped 3.9% as traders reassessed shorter term risk and reward. Scan beyond Quest Diagnostics and see how other...",
                "category": "company",
                "datetime": 1790183582,
                "headline": "Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch"
              },
              {
                "id": 142357932,
                "url": "https://finnhub.io/api/news?id=9e36425fe178bc4709a47624582e481fa85510e74d1222fa56d6866a9e993d90",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700551/image_2172700551.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Quest Diagnostics outlook: recurring testing demand & acquisitions support growth via hospital partnerships, dialysis & advanced diagnostics. More on DGX stock.",
                "category": "company",
                "datetime": 1790153451,
                "headline": "Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds"
              },
              {
                "id": 142343168,
                "url": "https://finnhub.io/api/news?id=038be9e8835d6646a1edcfd73c166a149aa77b0857c0e85a501ba91781969b3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics has delivered a strong run in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current share price still aligned with the cash the business is expected to generate over time, or has sentiment moved ahead of its underlying economics? Over the past 3 years, Quest Diagnostics has returned 108.9%, which puts real weight on whether that gain is grounded in durable cash flows rather than just multiple expansion. A recent...",
                "category": "company",
                "datetime": 1790111776,
                "headline": "Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns"
              },
              {
                "id": 142343169,
                "url": "https://finnhub.io/api/news?id=f51891e6b50a33e2225807bf2c70868ec49a46eace8ca870fd0fa16effd1209e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its third quarter 2026 financial results on Thursday, October 22, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
                "category": "company",
                "datetime": 1790108880,
                "headline": "Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026"
              },
              {
                "id": 142340992,
                "url": "https://finnhub.io/api/news?id=7f9451e056dd0c45a4304b88f0f9ccd9306f02bc7a8be5192dacae80dd8a134d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Stock Market Today: The Dow Jones index was lower after President Trump threatened Iran at the UN. Apple stock is near a buy point.",
                "category": "company",
                "datetime": 1790098711,
                "headline": "Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)"
              },
              {
                "id": 142340543,
                "url": "https://finnhub.io/api/news?id=3676ae49763de619be9f5fe2e63a7f07bcf3e24bbc465dc75e6bdb876230f298",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.",
                "category": "company",
                "datetime": 1790096700,
                "headline": "These S&P500 stocks have an unusual volume in today's session"
              },
              {
                "id": 142340388,
                "url": "https://finnhub.io/api/news?id=f2b585db9bcaae9e84130e615a8e8ef41261f486b04f1b7c75b84e8417f50f6d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1790094901,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 142340108,
                "url": "https://finnhub.io/api/news?id=7ba6201b058414a5b6972eb4c07b92c2f611694434c01ec3676864195808afe1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "The government thinks it's been overpaying Quest Diagnostics. They plan to stop doing that next year.",
                "category": "company",
                "datetime": 1790092667,
                "headline": "Why Quest Diagnostics Holdings Stock Dropped Today"
              },
              {
                "id": 142339965,
                "url": "https://finnhub.io/api/news?id=d1b6e8b524d0647dcaeec0b1a5b6abcaaf33defc75d8f66fc0c8d15a8e837148",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid whole genome and exome sequencing, next-generation sequencing, chromosomal microarrays and personalized neonatal care. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes key trends, technologies, segments, regional opportunities and leading companies, in",
                "category": "company",
                "datetime": 1790092440,
                "headline": "NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)"
              },
              {
                "id": 142339145,
                "url": "https://finnhub.io/api/news?id=f0446e18c84e837a73cc227d0f99d6763ecece1442cb743bfc7cda0da9c0f348",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1790087701,
                "headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
              },
              {
                "id": 142338103,
                "url": "https://finnhub.io/api/news?id=4401faec34b0aaa7836bc4c94e2745f0faaa5a933c0af5da81443dbec3f44bcb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.",
                "category": "company",
                "datetime": 1790085600,
                "headline": "Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure"
              },
              {
                "id": 142338104,
                "url": "https://finnhub.io/api/news?id=5215abeb2634d2e41b0915055aa5ef030cbf4b8eecbec9bed4a3c64d0351b745",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) and Labcorp (LH) shares fell in Tuesday premarket trading after the Centers",
                "category": "company",
                "datetime": 1790081212,
                "headline": "Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services"
              },
              {
                "id": 142337151,
                "url": "https://finnhub.io/api/news?id=ec15db9f3538528033e3a2b785c80a05463d3015aa798d3d099f3d82dfb34f1d",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.",
                "category": "company",
                "datetime": 1790080501,
                "headline": "Discover the top S&P500 movers in Tuesday's pre-market session."
              },
              {
                "id": 142338105,
                "url": "https://finnhub.io/api/news?id=0ddb1180ed60687db2d4be2df12a1369e2e796f69a49ec3ce7f075a2a7dce3bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.",
                "category": "company",
                "datetime": 1790080080,
                "headline": "Is This the Right Time to Add DGX Stock to Your Portfolio?"
              },
              {
                "id": 142340903,
                "url": "https://finnhub.io/api/news?id=0038cdfe7ff456daae6d1d328d374892016f3ea30e0fa66c2020ba00ba32c252",
                "image": "https://image.cnbcfm.com/api/v1/image/107419247-1716474869682-gettyimages-2120209340-64393_48_ms_2421.jpeg?v=1790098111&w=1920&h=1080",
                "source": "CNBC",
                "related": "DGX",
                "summary": "These are the stocks posting the largest moves midday.",
                "category": "company",
                "datetime": 1790079522,
                "headline": "Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more"
              },
              {
                "id": 142341306,
                "url": "https://finnhub.io/api/news?id=a71b9de87d209370f6319257c8942174ad27d5b639cb870a2f9cf782b0777741",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics has outperformed the Nasdaq over the past year, and analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1790078212,
                "headline": "Is Quest Diagnostics Stock Outperforming the Nasdaq?"
              },
              {
                "id": 142336978,
                "url": "https://finnhub.io/api/news?id=f1182ee95aa158cd4e64c93fec0fe6aa89a804fc357f25c80bbb04d312374656",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Investing.com - U.S. stock index futures steadied on Tuesday, following a strong session on Wall Street that saw the benchmark S&P 500 post its best day since August, helped by gains in artificial intelligence-linked stocks.",
                "category": "company",
                "datetime": 1790078144,
                "headline": "Premarket movers: Quest, Labcorp hit by CMS cuts"
              },
              {
                "id": 142338041,
                "url": "https://finnhub.io/api/news?id=3e0d174be2c852517a09542bfcb22c078c10e5aab66134bc391405284e08e1bf",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Portland--Or--Usa---Sep-4--2025-Homepage.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "CMS proposes 2027 Medicare lab rates, estimating $1 billion in annual taxpayer savings as payments align with private rates.",
                "category": "company",
                "datetime": 1790064655,
                "headline": "CMS Targets $1 Billion in Annual Savings With new Medicare Lab Payment Rates — Here’s What Could Change in 2027"
              },
              {
                "id": 142338042,
                "url": "https://finnhub.io/api/news?id=5fbe59656eb7c8e519203883d87a9ba7e725d627ad9c93744d9bd2b9cb6b416c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Stockholm--Sweden---October-8--2021-An-O.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostics, Rambus and others also declined premarket.",
                "category": "company",
                "datetime": 1790064067,
                "headline": "Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session"
              },
              {
                "id": 142340847,
                "url": "https://finnhub.io/api/news?id=1a3dcec5e48d410e2b1bfe59cbaf3923fc48e925527b6fa1ef1214e10e7de391",
                "image": "https://image.cnbcfm.com/api/v1/image/108192542-17564859632025-08-29t163100z_183075094_rc28ggaso5se_rtrmadp_0_on-hldg-results.jpeg?v=1756486078&w=1920&h=1080",
                "source": "CNBC",
                "related": "DGX",
                "summary": "These are the stocks posting the largest moves in early trading.",
                "category": "company",
                "datetime": 1790063373,
                "headline": "Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more "
              },
              {
                "id": 142337396,
                "url": "https://finnhub.io/api/news?id=7491d828c68bc1cb16df1464f12b93a2ed591c42e1565441c46468c4b46e2e1e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/The-Real-Villains-No-Longer-Hide.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Vicor jumped 11% premarket after raising Q3 growth guidance above 20%; TOPS, FBGL and QNME led other gainers.",
                "category": "company",
                "datetime": 1790055031,
                "headline": "Why Vicor Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket"
              },
              {
                "id": 142337470,
                "url": "https://finnhub.io/api/news?id=5c389d182d0729ba00bed5398594278c770ae22bb653f7a50cf68140cd412bc9",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Gainers\n\nMilestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday&#39;s after-market session. The company&#39;s market cap stands at $36.9 million. \nEvotec (NASDAQ:EVO) stock rose 8.44% to",
                "category": "company",
                "datetime": 1790010367,
                "headline": "12 Health Care Stocks Moving In Monday's After-Market Session"
              },
              {
                "id": 142314530,
                "url": "https://finnhub.io/api/news?id=351177f1d47b514bcc8a183bc924d38c93b7558751778d3c960cf36c2c1941b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (NYSE:DGX) CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth, consumer-health demand and partnerships rather than a heavier-than-expected pace of acquisitions. D",
                "category": "company",
                "datetime": 1789999330,
                "headline": "Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges"
              },
              {
                "id": 142311097,
                "url": "https://finnhub.io/api/news?id=549978088471503f39ef8adfc2316186f5ce7fc93dab84136070f50605ea2d73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Market uncertainty persists, but Zacks highlights strong gains across key portfolios and stocks, including PBF, PLTR and ADBE",
                "category": "company",
                "datetime": 1789992600,
                "headline": "Beat the Market Like Zacks: PBF, Palantir, Adobe in Focus"
              },
              {
                "id": 142313054,
                "url": "https://finnhub.io/api/news?id=3c78eb32d5eeb8295fa80c578cf9e54fa18cb97df559f696903c7f45af3604e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Nearly one in three patients found to have antibodies against the bacterium that causes Lyme disease also had antibodies against one or more additional tick-borne pathogens, according to a new study by researchers from Quest Diagnostics (NYSE: DGX) and the University of North Carolina at Chapel Hill.",
                "category": "company",
                "datetime": 1789992180,
                "headline": "Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics"
              },
              {
                "id": 142312445,
                "url": "https://finnhub.io/api/news?id=a88fe3314c79e8d454a01552d14cb77e1a9437dff5db27b2ceaee866cb1d31e5",
                "image": "",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Truist Securities  analyst David Macdonald   maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target from $250 to $260.",
                "category": "company",
                "datetime": 1789981671,
                "headline": "Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $260"
              },
              {
                "id": 142312446,
                "url": "https://finnhub.io/api/news?id=b85e02d4bea66182a8dbb2ce386581296b35e69bfed6c8f4ef67278e22f613e0",
                "image": "",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "New study by researchers from Quest Diagnostics (NYSE:DGX) and the University of North Carolina at Chapel Hill. Published in JAMA Network Open, the study, titled &#34;Coseropositivity to Tick-Borne Pathogens Among",
                "category": "company",
                "datetime": 1789978088,
                "headline": "Quest Diagnostics Study Indicates That Nearly One In Three Patients With Antibodies Against Bacterium That Causes Lyme Disease Also Had Antibodies Against One Or More Additional Tick-Borne Pathogens"
              },
              {
                "id": 142225152,
                "url": "https://finnhub.io/api/news?id=355c03f661bd93e470abbdb17b5b22b8907769b7958f9e4c607be6bc4b7480f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Fed hikes rates and signals another, putting MGEE, ADM, DOLE and DGX in focus as low-beta defensive picks.",
                "category": "company",
                "datetime": 1789649760,
                "headline": "Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive Picks"
              },
              {
                "id": 142195441,
                "url": "https://finnhub.io/api/news?id=1ffb6b8ee640f62a432d9ed6fc9c97319640f57308c68c080f2c1ff301be27ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1789564502,
                "headline": "Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?"
              },
              {
                "id": 142195442,
                "url": "https://finnhub.io/api/news?id=5f49404a1d066bb0c796e28f63a739f547f3fa8629f60e677951b1751d8a54fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "A new national survey finds the overwhelming majority of American voters rely on diagnostic laboratory testing to guide their healthcare decisions and are deeply concerned about scheduled Medicare payment cuts that could put that access at risk.",
                "category": "company",
                "datetime": 1789560180,
                "headline": "Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics"
              },
              {
                "id": 142167113,
                "url": "https://finnhub.io/api/news?id=b9533ba462e02bc4cdd69ebe009cce3b112c1338397a301218653d5b059ea426",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1789499101,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 142166319,
                "url": "https://finnhub.io/api/news?id=2e026f55abbf3ff2290abb66c1cf389d6e9b119a0016b17e326f84773da4e2c6",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (DGX) 2026 Global Healthcare Conference September 15, 2026 10:50 AM EDTCompany ParticipantsJames Davis - Chairman, CEO &...",
                "category": "company",
                "datetime": 1789480905,
                "headline": "Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript"
              },
              {
                "id": 142194774,
                "url": "https://finnhub.io/api/news?id=d1cab808ccf45cf13f1263e44cacc1adc587155103fca3659b6bbe4aa4db95f1",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/15/Stock-Market-Graph-Crashing-Down--Wall-S.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.",
                "category": "company",
                "datetime": 1789478829,
                "headline": "10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today"
              },
              {
                "id": 142138925,
                "url": "https://finnhub.io/api/news?id=bad7a27a955426b55fb09f9a409ec2144d8329e93442bc5c62eaa70c361e1be8",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (DGX) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsSam Samad -...",
                "category": "company",
                "datetime": 1789391505,
                "headline": "Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142029718,
                "url": "https://finnhub.io/api/news?id=df890eec6f1a2d6097b529a61c7a9ae646433d195e74ad03041a926884182cd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a tailored Quest laboratory test panel that includes over 50 biomarkers directly through the app on iPhone and iPad later this year. Apple first announced the upcoming update today at its September event.",
                "category": "company",
                "datetime": 1788984060,
                "headline": "Apple Health app Users to be Able to Order Labs from Quest Diagnostics"
              },
              {
                "id": 141951221,
                "url": "https://finnhub.io/api/news?id=5f0ccb5ba37ed2618b1c737f27fa3e8f9f760cf7074a72a068ccba82d24d4b12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "J. E. Davis disposed of 8% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement, retaining $28.9 million in company stock.",
                "category": "company",
                "datetime": 1788873661,
                "headline": "Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million"
              },
              {
                "id": 142027783,
                "url": "https://finnhub.io/api/news?id=800342fa032d4ffa9f0fe8c6eacc7f273f4182a62ae6d9c3a561f8cf138becb2",
                "image": "",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "UBS  analyst Kevin Caliendo   maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $232 to $245.",
                "category": "company",
                "datetime": 1788872310,
                "headline": "UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $245"
              },
              {
                "id": 141481712,
                "url": "https://finnhub.io/api/news?id=32dc6369c8c4692854a03ad7a10e5e7b739bfc7119a1fc5618cdb3c137eb677e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access. Roche Holding AG and Eli Lilly and Company (NYSE:LLY) may now have a simpler way to help physicians evaluate certain patients. The FDA has cleared Elecsys pTau217, which is a blood test that helps identify whether […]",
                "category": "company",
                "datetime": 1788568671,
                "headline": "Could Roche and Lilly’s Blood Test Make Alzheimer’s Assessment More Accessible?"
              },
              {
                "id": 141438225,
                "url": "https://finnhub.io/api/news?id=2bf55cc0ae8c14624d700fbe2bf2c06157061782e7f4dc6e23aa264b1b3689a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "The global clinical laboratory services market was valued at USD 274.6 billion in 2025 and is forecast to reach USD 468.2 billion by 2036, rising from USD 298.4 billion in 2026 at a 4.6% CAGR. Growth is driven by chronic diseases, preventive healthcare, molecular diagnostics, genomic testing, precision medicine, laboratory automation, AI-enabled diagnostics, and at-home testing. North America leads, while Asia-Pacific is set for the fastest growth. The report analyzes key segments, regions, oppo",
                "category": "company",
                "datetime": 1788532680,
                "headline": "Clinical Laboratory Services Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)"
              },
              {
                "id": 141408008,
                "url": "https://finnhub.io/api/news?id=7e265a133c957b1e633a2178b581bff46b7f58d4be1a68ea313b16f299e10419",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood-based Alzheimer’s tests accessible through Quest’s U.S. collection network. Together, these moves highlight Quest’s push to deepen its role in advanced kidney, brain health, and consumer-oriented wellness testing...",
                "category": "company",
                "datetime": 1788498563,
                "headline": "Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX"
              },
              {
                "id": 141400633,
                "url": "https://finnhub.io/api/news?id=595b73bf89e80d13752af49c883469a8239d7018da51accdfc2ed2fe3801f203",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788449411,
                "headline": "Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?"
              },
              {
                "id": 141362285,
                "url": "https://finnhub.io/api/news?id=7cc64918f3b60782ab2fbcbefa34e6aa0b5f06d064dc3153c595d7e299f4f42e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.",
                "category": "company",
                "datetime": 1788208182,
                "headline": "Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 7,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.7,
            "source_article_count": 43,
            "discarded_article_count": 36
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.7,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.4,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.4,
            "vcp_reason": "站上MA50;Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 1007403.3333333334,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1289130,
              "avg_vol_20": 1106955,
              "avg_vol_30": 1007403.3333333334,
              "range_pct_10": 0.09140144332255229,
              "range_pct_20": 0.09140144332255229,
              "range_pct_30": 0.09140144332255229,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.2796562780217124,
              "dist_to_20d_high": 0.05031341424208329,
              "down_shrink_days": 1,
              "breakout_level_20d": 248.84,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 1
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.578537467055795,
              "turnoverUsdM": 175.278551417,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DGX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 224.1328,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.2,
            "take_profit_price": 248.136,
            "target_multiplier": 1.6,
            "technical_strength": 1.48,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.15707493411159,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 71.43,
    "atr": {
      "atr": 6.0936,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.58
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -38.36
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0934
    },
    "kdj": {
      "d": 55.1,
      "j": 30.85,
      "k": 47.01,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 49.95
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -9295400,
      "recentSlope": -413300,
      "previousSlope": -350840
    },
    "rsi": 48.99,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 234.8186,
      "position": "SAR喺價下",
      "distancePct": 0.64,
      "previousTrend": "上升"
    },
    "ma50": 235.7046,
    "macd": {
      "macd": 0.5199415094540427,
      "trend": "中性偏多",
      "signal": 1.5760031015186575,
      "histogram": -1.0560615920646148
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 239.05,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.67,
      "score": 2,
      "avgVolume": 1102050,
      "currentVolume": 741700
    },
    "derived": {
      "ma20": 239.262,
      "ma50": 235.7046,
      "prevClose": 236.59,
      "avgVolume10": 1263620,
      "avgVolume20": 1102050,
      "changePercent": -0.11,
      "avgVolumeForScore": 1102050
    },
    "ma_cross": {
      "ma20": 239.262,
      "ma50": 235.7046,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 239.6765,
      "prevMa50": 235.1664,
      "spreadPct": 1.51,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 229.3454,
      "upper": 249.1786,
      "position": "中間"
    },
    "rsi_short": 19.61,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.67
    }
  }
}

Raw metrics JSON

{
  "close": 236.32,
  "volume": 741700,
  "changePercent": -0.11
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.